These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8243566)

  • 1. Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells.
    Bullock G; Tang C; Tourkina E; Ibrado AM; Lutzky J; Huang Y; Mahoney ME; Bhalla K
    Exp Hematol; 1993 Dec; 21(13):1640-7. PubMed ID: 8243566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosphamide-mediated reduction of glutathione levels and cytotoxicity in normal and leukemic bone marrow progenitor cells.
    Bhalla K; Bullock G; Lutzky J; Holladay C; Ibrado AM; Jasiok M; Singh S
    Leukemia; 1992 Aug; 6(8):814-9. PubMed ID: 1640734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells.
    Bhalla K; Ibrado AM; Tourkina E; Tang C; Mahoney ME; Huang Y
    Leukemia; 1993 Apr; 7(4):563-8. PubMed ID: 8096557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
    Bullock G; Ray S; Reed J; Miyashita T; Maria Ibrado A; Huang Y; Bhalla K
    Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells.
    Bhalla K; Tang C; Ibrado AM; Grant S; Tourkina E; Holladay C; Hughes M; Mahoney ME; Huang Y
    Blood; 1992 Dec; 80(11):2883-90. PubMed ID: 1450413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
    Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.
    Askew DS; Ashmun RA; Simmons BC; Cleveland JL
    Oncogene; 1991 Oct; 6(10):1915-22. PubMed ID: 1923514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Bcl-2 on ionizing radiation and 1-beta-D-arabinofuranosylcytosine-induced internucleosomal DNA fragmentation and cell survival in human myeloid leukemia cells.
    Manome Y; Weichselbaum RR; Kufe DW; Fine HA
    Oncol Res; 1993; 5(3):139-44. PubMed ID: 8260751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein.
    Ponnathpur V; Ibrado AM; Reed JC; Ray S; Huang Y; Self S; Bullock G; Nawabi A; Bhalla K
    Clin Cancer Res; 1995 Nov; 1(11):1399-406. PubMed ID: 9815937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of IFN-alpha combined with IL-6 on cell growth and related genes expression and apoptosis of bone marrow cells from CGL patients].
    Chen H; Tang L; Peng X; Luo Z; Luo S; Tan W
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jul; 21(7):341-4. PubMed ID: 11877000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesnarinone exhibits antitumor effect against myeloid leukemia cells via apoptosis.
    Fujiwara H; Arima N; Otsubo H; Matsushita K; Hidaka S; Arimura K; Kukita T; Yamaguchi K; Tanaka H
    Exp Hematol; 1997 Oct; 25(11):1180-6. PubMed ID: 9328455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptotic DNA fragmentation and c-jun downregulation in human myeloid leukemia cells by the permeant Ca2+ chelator BAPTA/AM.
    Grant S; Freemerman AJ; Gregory PC; Martin HA; Turner AJ; Mikkelsen R; Chelliah J; Yanovich S; Jarvis WD
    Oncol Res; 1995; 7(7-8):381-92. PubMed ID: 8747601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells.
    Feng R; Shen S; Hui H; Jin M
    Chin Med J (Engl); 1997 Nov; 110(11):847-50. PubMed ID: 9772416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity.
    Vanhaesebroeck B; Reed JC; De Valck D; Grooten J; Miyashita T; Tanaka S; Beyaert R; Van Roy F; Fiers W
    Oncogene; 1993 Apr; 8(4):1075-81. PubMed ID: 8455935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
    Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
    Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hemopoietic growth factors G-CSF and pIXY 321 on the activity of high dose Ara-C in human myeloid leukemia cells.
    Bhalla K; Tourkina E; Huang Y; Tang C; Mahoney ME; Ibrado AM
    Leuk Lymphoma; 1993; 10 Suppl():123-31. PubMed ID: 7683227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1.
    DiGiuseppe JA; Kastan MB; Weng LJ; Gore SD
    In Vivo; 1999; 13(1):1-6. PubMed ID: 10218124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
    Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine.
    Gunji H; Kharbanda S; Kufe D
    Cancer Res; 1991 Jan; 51(2):741-3. PubMed ID: 1985792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.